FDG-PET in the clinically negative neck in oral squamous cell carcinoma

Laryngoscope

Volumn 116, Issue 5, 2006, Pages 809-813

  Wensing, Bart M ^a   Vogel, Wouter V ^a   Marres, Henri A M ^a   Merkx, Matthias A W ^a   Postema, Ernst J ^a,b   Oyen, Wim J G ^a   Van Den Hoogen, Frank J A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

Author keywords

Cervical lymph node metastasis; FDG PET; Oral cavity; Squamous cell carcinoma; Supraomohyoid neck dissection

Indexed keywords

FLUORODEOXYGLUCOSE; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER STAGING; CERVICAL LYMPH NODE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MOUTH CARCINOMA; NECK DISSECTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SENSIBILITY; SQUAMOUS CELL CARCINOMA; COMPARATIVE STUDY; CYTODIAGNOSIS; IMMUNOHISTOCHEMISTRY; LABORATORY DIAGNOSIS; METASTASIS; MIDDLE AGED; MOUTH TUMOR; NECK; NEEDLE BIOPSY; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; CYTODIAGNOSIS; FALSE NEGATIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NECK; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 33745245722     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000209151.78362.d0     Document Type: Article

References (20)

1. Hanley DJ. Supraomohyoid neck dissection. Br J Plast Surg 1980;33:136-137.
2. Medina JE, Byers RM. Supraomohyoid neck dissection: rationale, indications, and surgical technique. Head Neck 1989;11:111-122.
3. Brazilian Head Neck Cancer Study Group. Results of a prospective trial on elective modified radical classical versus supraomohyoid neck dissection in the management of oral squamous carcinoma. Am J Surg 1998;176:422-427.
4. Shah JP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg 1990;160:405-409.
5. Kerrebijn JD, Freeman JL, Irish JC, et al. Supraomohyoid neck dissection. Is it diagnostic or therapeutic? Head Neck 1999;21:39-42.
6. Weiss MH, Harrison LB, Isaacs RS. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg 1994;120:699-702.
7. van den Brekel MW, Castelijns JA, Stel HV, et al. Occult metastatic neck disease: detection with US and US-guided fine-needle aspiration cytology. Radiology 1992;180:457-461.
8. Takes RP, Righi PD, Meeuwis CA, et al. The value of ultrasound with ultrasound-guided fine-needle aspiration biopsy compared to computed tomography in the detection of regional metastases in the clinically negative neck. Int J Radiat Oncol Biol Phys 1998;40:1027-1032.
9. Nieuwenhuis EJ, Castelijns JA, Pijpers R, et al. Wait-and-see policy for the N0 neck in early-stage oral and oropharyngeal squamous cell carcinoma using ultrasonography-guided cytology: is there a role for identification of the sentinel node? Head Neck 2002;24:282-289.
10. van den Hoogen FJA, Westerbeek BC, Joosten FB, Bruaset I, Marres HA. Supraomohyoid neck dissection in the ultrasonographically and clinically negative neck in oral carcinoma. Clin Otolaryngol 2001;26:340.
11. Brouwer J, de Bree R, Comans EF, Castelijns JA, Hoekstra OS, Leemans CR. Positron emission tomography using [(18)F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior? Eur Arch Otorhinolaryngol 2004;261:479-483.
12. Myers LL, Wax MK. Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer. J Otolaryngol 1998;27:342-347.
13. Hyde NC, Prvulovich E, Newman L, Waddington WA, Visvikis D, Ell P. A new approach to pre-treatment assessment of the N0 neck in oral squamous cell carcinoma: the role of sentinel node biopsy and positron emission tomography. Oral Oncol 2003;39:350-360.
14. Andersen PE, Cambronero E, Shaha AR, Shah JP. The extent of neck disease after regional failure during observation of the N0 neck. Am J Surg 1996;172:689-691.
15. Ross GL, Soutar DS, MacDonald GD, et al. Sentinel node biopsy in head and neck cancer: preliminary results of a multicenter trial. Ann Surg Oncol 2004;11:690-696.
16. Ferlito A, Shaha AR, Rinaldo A, Pellitteri PK, Mondin V, Byers RM. 'Skip metastases' from head and neck cancers. Acta Otolaryngol 2002;22:788-791.
17. Ambrosch P, Brinck U. Detection of nodal micrometastases in head and neck cancer by serial sectioning and immunostaining. Oncology (Huntingt) 1996;10:1226-1229.
18. Woolgar JA. Micrometastasis in oral/oropharyngeal squamous cell carcinoma: incidence, histopathological features and clinical implications. Br J Oral Maxillofacial Surg 1999;37:181-186.
19. Pitman KT, Ferlito A, Devaney KO, Shaha AR, Rinaldo A. Sentinel lymph node biopsy in head and neck cancer. Oral Oncol 2003;39:343-349.
20. Civantos FJ, Gomez C, Duque C, et al. Sentinel node biopsy in oral cavity cancer: correlation with PET scan and immunohistochemistry. Head Neck 2003;25:1-9.